drugset / Trial / NCT07463053

Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers

NCT07463053

Phase 1 Not yet recruiting 8 enrolled Jemincare Zhejiang Hangyu Pharmaceutical Co., Ltd. · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A phase 1 healthy volunteer study to assess the excretion and metabolism as well as the absolute bioavailability of oral JMKX003142. The study will be conducted in two parts: Part 1 to assess the mass balance of JMKX003142 using orally administered radiolabelled JMKX003142; part 2 will assess the absolute bioavailability using JMKX003142 and radiolabelled JMKX003142 as intravenous and oral forms

Timeline

Start
2026-03-18
Primary completion
2026-05-07
Completion
2026-06-11

Drugs

EvaluationDrugModalityDoseRoute
Subject JMKX003142 Unknown Oral